✦ LIBER ✦

Phase II trial of liposomal doxorubicin at 40 mg/m2 every 4 weeks in endometrial carcinoma: A Gynecologic Oncology Group Study

✍ Scribed by Howard D. Homesley; John A. Blessing; Joel Sorosky; Gary Reid; Katherine Y. Look

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of trastuzumab in women w

✍ Gini F. Fleming; Michael W. Sill; Kathleen M. Darcy; D. Scott McMeekin; J. Tate 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 477 KB

A Phase II Trial of Anastrozole in Advan

✍ Peter G. Rose; Virginia L. Brunetto; Linda VanLe; Jeffrey Bell; Joan L. Walker; 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 45 KB

Phase II Trial of Pyrazoloacridine in Pa

✍ Steven C. Plaxe; John A. Blessing; Nader Husseinzadeh; Kenneth D. Webster; Janet 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 39 KB

A Phase I Trial of Prolonged Oral Etopos

✍ Peter G. Rose; Michael Rodriguez; Joan Walker; Benjamin Greer; Nancy Fusco; Will 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 43 KB

A Phase II Trial of Topotecan in Patient

✍ David Scott Miller; John A. Blessing; Samuel S. Lentz; Steven E. Waggoner 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Phase III Trial of Doxorubicin Plus Cisp

✍ Fleming, G. F. 📂 Article 📅 2004 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB